Parhaat Cite Podcastit (2024)

世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。今回取り上げた記事はこちら「Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies（邦題意訳：GLP-1を超える心代謝系治療薬のヒントは、冬眠するリスか、地道な運動か）」（日本語版）https://www.citeline.com/ja-jp/resources/hibernating-squirrels-and-exercise-in-a-pill※全文の閲覧には情…

1
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing 25:21

Play Pause

13h ago25:21

25:21

In this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairing software and predictive analytics with medications old and new to tailor drug dosing to each patient.Kirjoittanut Citeline

1
Leading PRO Discusses Plans For Administering State EPR Programs 36:59

1d ago36:59

36:59

In this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility laws launching next year. With a 1 July deadline to register for his PRO, Circular Action Alliance, Hite discusses steps companies should take now, how his organization will assist producers and expectat…

1
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast) 3:24

2d ago3:24

3:24

빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다.https://scrip.citeline.com/SC150256/Development-Versus-Dealmaking-How-To-Obtain-A-BlockbusterPlaylist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-miniKirjoittanut Citeline

1
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane 32:07

3d ago32:07

32:07

In this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strategy. Having grown the company with widely successful European OTC medical devices like Dr. Yglo, FungeX and Kidsner, Swane is perfectly placed to explain how to create and grow OTC brands. Swane also o…

1
Scrip's Five Must-Know Things - 20 May 2024 16:55

3d ago16:55

16:55

Audio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; blockbusters by indication; gene therapy struggles; sun shines on AstraZeneca and GSK; and Korean ventures look to Japan.https://scrip.citeline.com/SC150281/Quick-Listen-Scrips-Five-MustKnow-ThingsPla…

1
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation 38:55

5d ago38:55

38:55

Pink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would improve clinical trial diversity with tougher enforcement of the regulation (22:26), as some have suggested, and the FDA’s use of platform technology ideas for gene therapies not participating in the …

1
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma 16:04

6d ago16:04

16:04

Flora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market.Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZX…

1
Ep 86 April 2024 Fourth Circuit and Supreme Court Update 33:25

8d ago33:25

33:25

Jonathan Byrne and Alicia Penn of the District of South Carolina Federal Public Defender Office discuss recent Fourth Circuit and Supreme Court news.

1
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language) 35:28

8d ago35:28

35:28

In this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from the Pink Sheet in the US, discuss the planned US BIOSECURE Act and markup vote. Brian and Dexter also look at recent R&D updates from Chinese biopharma firms on their antibody-drug conjugate pipelines…

1
Scrip's Five Must-Know Things - 13 May 2024 14:29

10d ago14:29

14:29

Audio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria farewell; the next wave of cardiometabolics; Pfizer recruits prominent analyst: foundation pleas for China rare disease therapies; and Gossamer partners up for respiratory therapy.https://scrip.citeline.…

1
Episode 15: Digital Trust 20:20

13d ago20:20

20:20

In this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operation…

1
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta 29:28

16d ago29:28

29:28

In this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medicines packaging. Perrotta works for PA Consulting, which set up the Blister Pack Collective alongside consumer healthcare partners Haleon, Bayer and Sanofi. They are working with PulPac, which has inven…

1
Scrip's Five Must-Know Things - 7 May 2024 15:01

17d ago15:01

15:01

Audio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncology firm; strong growth but supply issues for Lilly; Novo and Lilly make their money work; BMS cuts jobs, costs; and Big Pharma’s support for bioventures.https://scrip.citeline.com/SC150211/Quick-Listen-…

1
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review 31:23

20d ago31:23

31:23

Pink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’s efforts to help the clinical trial modeling and simulation industry (16:22), and the UK’s MHRA plan to use artificial intelligence to assist in drug application reviews (21:05).More On These Topics From…

1
Digital Health Roundup: US FDA’s ‘Idea Lab’; Philips’ Roy Jakobs On AI Draft Framework; Apple Watch 6:35

23d ago6:35

6:35

In this month’s Digital Health Roundup, Medtech Insight’s Marion Webb highlights key interviews with Philips’ CEO Roy Jakobs on NAM’s draft framework on AI, BD’s CTO Beth McCombs R&D initiatives and HSS spine co-chair Sheeraz Qureshi on his vision for integrating AI tech. Hannah Daniel discusses the FDA’s new initiative to create an idea lab for me…

1
April Datamonitor Podcast 2024: AAN coverage 51:54

23d ago51:54

51:54

Flora and Emma are joined by Datamonitor’s CNS analysts Summer, Joseph, and Wen-Yu to discuss coverage from AAN.Other platforms (in addition to SoundCloud):Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vy…

1
21.04.2024 - Jean 15:1-17 - Jesus The True Vine (Simona Vilcu) 47:17

23d ago47:17

47:17

21.04.2024 - Jean 15:1-17 - Jesus The True Vine (Simona Vilcu) by La CitéKirjoittanut La Cité

1
14.04.2024 - Jean 14:14-31 - Promesse de Jésus d’Envoyer Un Autre Défenseur (Frederic Dalais) 29:07

23d ago29:07

29:07

14.04.2024 - Jean 14:14-31 - Promesse de Jésus d’Envoyer Un Autre Défenseur (Frederic Dalais) by La CitéKirjoittanut La Cité

1
07.04.2024 - Jean 14:1-14 (Frederic Dalais) 38:20

23d ago38:20

38:20

07.04.2024 - Jean 14:1-14 (Frederic Dalais) by La CitéKirjoittanut La Cité

1
31.03.2024 - Message de Pacques (Nathan de l'église Fireplace) 44:12

23d ago44:12

44:12

31.03.2024 - Message de Pacques (Nathan de l'église Fireplace) by La CitéKirjoittanut La Cité

1
Scrip's Five Must-Know Things - 30 April 2024 14:15

24d ago14:15

14:15

Audio roundup of selected biopharma industry content from Scrip over the business week ended 26 April 2024. In this episode: 2023’s top selling drugs and the COVID cliff; falling sales force Roche to reassess priorities; Phase III immunology win for Sanofi; BMS’s strong pipeline: and which companies could be acquired next.https://scrip.citeline.com…

1
2024 Global Generics & Biosimilars Awards 4:30

24d ago4:30

4:30

2024 Global Generics & Biosimilars Awards by CitelineKirjoittanut Citeline

1
Podcast: Facilitating Patient Monitoring in CAR-T Development 19:28

24d ago19:28

19:28

Learn how molecular technology is enhancing patient safety for CAR-T clinical trials. US FDA recently initiated class safety labeling changes after evaluating the safety of CAR-T cancer treatment therapies. What does this mean for developers in the CAR-T landscape? Listen to your free podcast to find out.Listen in on the conversation as experts fro…

1
Drug Fix: US FDA Biosimilar Strategy, Gene Therapy Accelerated Approvals, FDA v. Partisan Politics 34:14

27d ago34:14

34:14

Pink Sheet reporter and editors discuss the impact of FDA biosimilar promotion guidance on the future of the interchangeability designation (:34), upcoming guidance on accelerated approval for gene therapies (14:15), and partisan attacks on the agency from Capitol Hill (27:13).More On These Topics From The Pink SheetRx Advertising: Interchangeabili…

1
Dr. Xue Discusses Treatment Guideline Updates for COPD in This Q&A Session 10:15

27d ago10:15

10:15

Pulmonologist Bing Xue, MD, reviews the latest GOLD guidelines and discusses relevant topics regarding COPD treatment.Kirjoittanut Citeline

1
China Biotech Podcast - 26 April 2024 (Chinese and English Language) 28:19

27d ago28:19

28:19

Join Scrip's China-based editors Brian Yang and Dexter Yan in this Chinese/English podcast as they look at data presented to AACR by Chinese pharma firms and recent acquisitions of China-based companies. UK-based writer Andrew McConaghie also joins to provide his perspectives, including on the proposed US BIOSECURE Act.https://scrip.citeline.com/SC…

1
Future Governance & Oversight of the EU Medtech Regulatory System 55:58

29d ago55:58

55:58

Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.Kirjoittanut Citeline

1
Citeline - Cerba Research Podcast V2 19:28

30d ago19:28

19:28

Citeline - Cerba Research Podcast V2 by CitelineKirjoittanut Citeline

1
Scrip M&A Podcast: Are Buyers Coming For Viking, Verona, Altimmune, Xenon And Crinetics 45:57

1M ago45:57

45:57

Scrip's Joseph Haas, Kevin Grogan and Edwin Elmhirst talk about the biopharma M&A environment and which companies might look particularly appealing to potential acquirers.Kirjoittanut Citeline

1
Turning That Frown Upside Down: Treating Depression With Facial Botox Injections 18:38

1M ago18:38

18:38

In this episode of the In Vivo podcast, Eric Finzi, CEO of Healis Therapeutics, discusses how his company is targeting major depression, post-traumatic stress disorder and other mental illnesses using facial botox injections.Kirjoittanut Citeline

1
Over The Counter 22 April 2024 22:13

1M ago22:13

22:13

Helping Consumers ‘Tune In’ To Reliable Health Information, With Kaizo’s Anita Nahal“Consumers are rewriting the rules when it comes to where they are going for information and the type of information they are looking for,” reports Kaizo’s Anita Nahal, speaking to HBW Insight’s Over the Counter podcast about the agency’s latest Communicating Health…

1
Scrip's Five Must-Know Things - 22 April 2024 14:54

1M ago14:54

14:54

Audio roundup of selected biopharma industry content from Scrip over the business week ended 19 April 2024. In this episode: Teva’s immunology biosimilar launches; Intra-Cellular’s promising depression data; Phase III sleep apnea win for Lilly’s tirzepatide; an interview with Viking’s CEO; and China looks to define innovative drugs.https://scrip.ci…

1
Drug Fix: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development 30:58

1M ago30:58

30:58

Pink Sheet editors discuss Medicare spending projections for the Alzheimer’s treatment Leqembi (:28), Janet Woodcock’s new post-FDA role (12:28), and ongoing preparations for new pneumococcal vaccines that will reach the market soon (17:28).#business #pharmaMore On These Topics From The Pink SheetMedicare Spending Forecast For Leqembi Reflects CMS …

1
Next-Generation Diagnostics: "Breathomics" From Imspex 14:29

1M ago14:29

14:29

A new diagnostic technology to screen and triage individuals based on breath.Kirjoittanut Citeline

1
Ratio Therapeutics On BMS Buy-In, Radiopharma R&D Trends, AI And Assets 39:09

1M ago39:09

39:09

Scrip’s senior editor Vibha Ravi speaks with Jack Hoppin, CEO and chairman, and John Babich, chief scientific officer, at Ratio Therapeutics, about the company’s radiopharmaceuticals pipeline, investment by BMS, use of AI, trends and developments in radiopharma research like combining ADCs or PARP inhibitors and more.https://scrip.citeline.com/SC15…

1
China Biotech Podcast (Chinese- and English-language) - April 2024 29:08

1M ago29:08

29:08

In this Chinese- and English-language episode, guest speaker Treehill Partners co-founder Ali Parshadezah joins Brian Yang and Dexter Yan to discuss updates on the proposed US BIOSECURE Act and US-China biotech movements, including recent M&A activity.https://scrip.citeline.com/SC150090/China-Biotech-Podcast-BIOSECURE-Updates-GenmabProfound-Deal…

1
Scrip's Five Must-Know Things - 15 April 2024 15:42

1M ago15:42

15:42

Audio roundup of selected biopharma industry content from Scrip over the business week ended 12 April 2024. In this episode: the shifting sands of pharma R&D; big pharma oncology strategies; semaglutide’s promise in heart failure; AstraZeneca looks to multiple cancer modalities; and an interview with Astellas’s chief strategy officer.https://scrip.…

1
Drug Fix: US FDA Adcomm Open Public Hearings, Clinical Trial Diversity Plans, Stealth’s Elamipretide 38:41

1M ago38:41

38:41

Pink Sheet reporter and editors discuss Richard Pazdur’s call for more diverse opinions in FDA advisory committee meeting open public hearings (:36), agency questions about the stakeholders sponsors consult to execute clinical trial diversity plans (20:52), and Stealth BioTherapeutics’ application for the Barth Syndrome candidate elamipretide getti…

1
Ep 85 March 2024 Fourth Circuit Update 49:20

1M ago49:20

49:20

Jonathan Byrne and Andrew Grindrod of the District of Eastern Virginia Federal Public Defender Office discuss recent Fourth Circuit news.

1
In Conversation With 2024 In Vivo Rising Leader, Hanadie Yousef 30:11

1M ago30:11

30:11

In this episode, In Vivo speaks to 2024 Rising Leader Hanadie Yousef, CEO of Juvena Therapeutics, about her journey, the secretome as a source of therapeutics, longevity medicine and alternatives to GLP-1 inhibitors for obesity.Kirjoittanut Citeline

1
Scrip's Five Must-Know Things - 8 April 2024 14:23

2M ago14:23

14:23

Audio roundup of selected biopharma industry content from Scrip over the business week ended 5 April 2024. In this episode: Genmab buys into ADCs; Roivant set to take on AbbVie in uveitis; Ipsen signs firs ADC pact; South Korea looks to build biotech momentum; and the end of the road for Acorda.https://scrip.citeline.com/SC150062/Quick-Listen-Scrip…

1
Drug Fix: Relyvrio And Public Promises, Allergy Biomarker Adcomms, PMDA In The USA 21:24

2M ago21:24

21:24

Pink Sheet reporters and editor discuss the implications of Amylyx following through on its pledge to remove Relyvrio from the market after its trial failed (:32), an FDA idea to bring potential biomarkers for promising allergy and asthma treatments to advisory committees (9:08), and Japan’s PMDA opening an office in Washington D.C. (16:19).More On…

1
Medtech Connect Episode 14: Live From HIMSS 2024 6:21

2M ago6:21

6:21

In this episode, Medtech Insight regulatory reporter Hannah Daniel speaks to industry professionals at the Healthcare Information and Management Systems Society (HIMSS) 2024 conference about what they enjoy about the annual gathering and what excites them for the future.Kirjoittanut Citeline

1
피노바이오, 국내 ADC 생태계 발전에 기여할 것 (Korean-language podcast) 4:18

2M ago4:18

4:18

기술 수요와 공급의 '불균형' 속에서 국내 ADC 업체들은 생태계를 발전시키려 노력하고 있습니다. Scrip의 정두영 피노바이오 대표 인터뷰기사를 요약한 내용입니다.https://scrip.citeline.com/SC149716/How-Pinotbio-Is-Helping-Build-Koreas-ADC-EcosystemKirjoittanut Citeline

1
Scrip's Five Must-Know Things - 1 April 2024 14:34

2M ago14:34

14:34

Audio roundup of selected biopharma industry content from Scrip over the past business week. In this episode: Merck & Co progresses cardiovascular strategy; Novo purchase builds heart failure presence; CRL setbacks for Regeneron; ITF faces challenging Duchenne field; and AbbVie needs to freshen up.https://scrip.citeline.com/SC150030/Quick-Listen-Sc…

1
Analysing The Spin-Out Trend In Consumer Health, With HBW’s Malcolm Spicer And Tom Gallen 37:02

2M ago37:02

37:02

In this episode, HBW Insight’s Europe and US editors Tom Gallen and Malcolm Spicer bring their expertise to bear on the current the trend towards standalone OTC companies in global consumer health. We look at four major players: Haleon, which separated from GSK almost two years ago, Kenvue, soon to celebrate its first anniversary as a new company; …

1
March Datamonitor Podcast 2024: The US Inflation Reduction Act 23:18

2M ago23:18

23:18

Flora and Ian are joined by Datamonitor’s financial analyst Abby, who discusses the Inflation Reduction Act and drug pricing trends in the US.Other platforms (in addition to SoundCloud):Apple Podcasts -   https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZW…

Kuuntelemisen arvoisia podcasteja

Cite podcastit

Kuuntelemisen arvoisia podcasteja

Pikakäyttöopas